Demand for these medications has transformed Novo Nordisk and its rival Eli Lilly $LLY (LLY), the producer of competing drugs Mounjaro and Zepbound, into the largest pharma companies in the world
This was observed in a cohort of patients that met the Rome criteria for the entity, of whom only 4% were diagnosed with CVS.4 These data highlight the poor recognition of the syndrome, resulting in diagnostic delay and the consequently greater frequency of visits to the emergency room, increased health costs, and suboptimum treatment, with poor results for the patient.3,5,6 Thus, our aim was to carry out a detailed bibliographic review of the epidemiology, pathophysiology, subtypes, diagnostic criteria, and current management of CVS
Take the next step in your routine today
Compounded medications are not the same as, interchangeable with, or substitutes for any FDA-approved branded product, including Ozempic or Wegovy (registered trademarks of Novo Nordisk A/S)